** FILE ** Irvin Belin, a technician at Ortho-Clinical Diagnostics Inc., a Johnson & Johnson company, works with vials of Anti Sera, a blood typing system, at the plant in a Raritan, N.J. file photo from July 17, 2006. On Tuesday, July 31, 2007, health care giant Johnson & Johnson, said it would reduce its global work force by up to 4 percent, or almost 4,820 jobs, in a restructuring to cut costs due to a slump in sales of its heart stents and looming expirations for key drug patents over the next few years. (AP Photo/Mike Derer, File)